ArticleEuropean journal of clinical pharmacology2024

Evaluation of SLC6A2 and CYP2D6 polymorphisms' effects on atomoxetine treatment in attention deficit and hyperactivity disorder.

Ismail Hasan Kole et al.PubMed ↗Publisher ↗

No numbers read from the abstract.